2020-10-20

1: Marzocco S, Mazzon E, Pinto A, Autore G, Cuzzocrea S. Tyrphostin AG 126 reduces intestinal ischemia-reperfusion injury in the rat. Naunyn Schmiedebergs Arch Pharmacol. 2006 Feb;372(5):362-73. Epub 2006 Feb 17. PubMed PMID: 16485131.

2: Balachandra S, Genovese T, Mazzon E, Di Paola R, Thiemerman C, Siriwardena AK, Cuzzocrea S. Inhibition of tyrosine-kinase-mediated cellular signaling by tyrphostins AG 126 and AG556 modulates murine experimental acute pancreatitis. Surgery. 2005 Nov;138(5):913-23. PubMed PMID: 16291393.

3: Moore BA, Türler A, Pezzone MA, Dyer K, Grandis J, Bauer AJ. Tyrphostin AG 126 inhibits development of postoperative ileus induced by surgical manipulation of murine colon. Am J Physiol Gastrointest Liver Physiol. 2004 Feb;286(2):G214-24. Epub 2003 Sep 25. PubMed PMID: 14512290.

4: Dugo L, Chatterjee PK, Mazzon E, McDonald MC, Paola RD, Fulia F, Caputi AP, Thiemermann C, Cuzzocrea S. The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat. Intensive Care Med. 2002 Jun;28(6):775-88. Epub 2002 Apr 30. PubMed PMID: 12107686.

5: Cuzzocrea S, McDonald MC, Mazzon E, Mota-Filipe H, Lepore V, Ciccolo A, Terranova ML, Britti D, Caputi AP, Thiemermann C. The tyrosine kinase inhibitor tyrphostin AG 126 reduced the development of colitis in the rat. Lab Invest. 2000 Sep;80(9):1439-53. PubMed PMID: 11005212.